Dopamine genes and attention-deficit hyperactivity disorder: A review

Journal of Psychiatry and Neuroscience

Volumn 28, Issue 1, 2003, Pages 27-38

  DiMaio, Salvatore ^a   Grizenko, Nathalie ^a   Joober, Ridha ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Alleles; Attention deficit disorder with hyperactivity; Case control studies; Dopamine; Dopamine beta hydroxylase; Genes; Genetic predisposition to disease; Meta analysis; Minisatellite repeats; Molecular biology; Polymorphism, genetics; Receptors, dopamine

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER; GENE PRODUCT;

ALLELISM; ATTENTION DEFICIT DISORDER; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE FUNCTION; GENE MUTATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; NONHUMAN; PATHOGENESIS; PHENOTYPE; REVIEW;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; PHENOTYPE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4;

EID: 0037223609     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Brown RT, Freeman WS, Perrin JM, Stein MT, Amler RW, Feldman HM, et al. Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics 2001;107:E43.
2. Scahill L, Schwab-Stone M. Epidemiology of ADHD in school-age children. Child Adolesc Psychiatr Clin N Am 2000;9:541-55.
3. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJS, Jensen PS, Cantwell DP. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998;351:429-33.
4. Wolraich MI, Hannah JN, Baumgaertel A, Feurer ID. Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a cotmtry-wide sample. J Dev Behav Pediatr 1998;19:162-8.
5. Brown TE. Attention-deficit disorders and comorbidities in children, adolescents and adults. Washington: American Psychiatric Press; 2000.
6. Hechtman LT. Families of children with attention deficit hyperactivity disorder: A review. Can J Psychiatry 1996;41:350-60.
7. Faraone SV, Biederman J. Genetics of attention-deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 1994;3:285-302.
8. Faraone SV, Biederman J. Is attention deficit hyperactivity disorder familial? Harv Rev Psychiatry 1994;1:271-87.
9. Faraone SV, Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 1998;44:951-8.
10. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H, et al. Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clin Genet 2000;57:178-96.
11. Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL, et al. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet 2002;70:1183-96.
12. Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Cohen H. High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder. Am J Psychiatry 1999;156:1209-15.
13. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996;379:606-12.
14. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM, et al. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 1994;79:729-42.
15. Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ, Robbins TW. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 2000;20:1208-15.
16. Accili D, Fishburn CS, Drago J, Steiner H, Lachowicz JE, Park BH, et al. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci U S A 1996;93:1945-9.
17. 1 receptors in prefrontal cells and circuits. Brain Res Rev 2000;31:295-301.
18. Hess EJ, Rogan PK, Domoto M, Tinker DE, Ladda RL, Ramer JC. Absence of linkage of apparently single gene mediated ADHD with the human syntenic region of the mouse mutant coloboma. Am J Med Genet 1995;60:573-9.
19. Comings DE. The clinical and molecular genetics of ADHD and Tourette syndrome: Two related polygenic disorders. Ann NY Acad Sci 2001;931:50-83.
20. Terwilliger JD, Weiss KM. Linkage disequilibrium mapping of complex disease: fantasy or reality? Curr Opin Biotechnol 1998;9:578-94.
21. Falk CT, Rubinstein P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 1987;51(Pt3):227-33.
22. Ewens WJ, Spielman RS. The transmission/disequilibium test: history, subdivision, and admixture. Am J Hum Genet 2000;57:455-64.
23. Morton NE, Collins A. Tests and estimates of allelic association in complex inheritance. Proc Natl Acad Sci U S A 1998;95:11389-93.
24. Schulze TG, Muller DJ, Krauss H, Gross M, Bauer I, Fangerau-Lefevre H, et al. Caught in the trio trap? Potential selection bias inherent to association studies using parent-offspring trios. Am J Med Genet 2001;105:351-3.
25. Giros B, Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, et al. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 1992;42:383-90.
26. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, et al. Human dopamine transpoter gene maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992;14:1104-6.
27. Barr CL, Xu C, Kroft J, Feng Y, Wigg K, Zai G, et al. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder. Biol Psychiatry 2001;49:333-9.
28. Roman T, Schmitz M, Polanczyk G, Eizirik M, Rohde LA, Hutz MH. Attention-deficit hyperactivity disorder: A study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J Med Genet 2001;105:471-8.
29. Curran S, Mill J, Tahir E, Kent L, Richards S, Gould A, et al. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry 2001;6:425-8.
30. Holmes J, Payton A, Barret JH, Hever T, Fitzpatrick H, Trumper AL, et al. A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol Psychiatry 2000;5:523-30.
31. Palmer CG, Bailey JN, Ramsey C, Cantwell D, Sinsheimer JS, Del'Homme M, et al. No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample. Psychiatr Genet 1999;9:157-60.
32. Daly G, Hawi Z, Fitzgerald M, Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 1999;4:192-6.
33. Waldman ID, Rowe DC, Abramowitz S, Kozel T, Mohr JH, Sherman L, et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 1998;63:1767-76.
34. Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995;56:993-8.
35. Todd RD, Jong Y-JI, Lobos EA, Reich W, Heath AC, Neuman RJ. No association of the dopamine transporter gene 3′ VNTR polymorphism with ADHD subtypes in a population sample of twins. Am J Med Genet 2001;105:745-8.
36. Swanson JM, Flodman P, Kennedy J, Spence MA, Moyzis R, Schuck S, et al. Dopamine genes and ADHD. Neurosci Biobehav Rev 2000;24:21-5.
37. Martinez D, Gelernter J, Abi-Dargham A, van Dyke C, Kegeles L, Innis RB, et al. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 2001;24:553-60.
38. Winsberg BG, Comings DE. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J Am Acad Child Adolesc Psychiatry 1999;38:1474-7.
39. Karatekin C, Asarnow RF. Working memory in childhood-onset schizophrenia and attention-deficit/hyperactivity disorder. Psychiatry Res 1998;80:165-76.
40. Balk JH, Picetti R, Saiardi A, Thiriet G, Dierich A, Depaulis A, et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 1995;377:424-8.
41. Kidd KK, Morar B, Castiglione CM, Zhao H, Pakstis AJ, Speed WC, et al. A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus. Hum Genet 1998;103:211-27.
42. Comings DE, Wu S, Chiu C, Ring RH, Gade R, Ahn C, et al. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effects of the three dopaminergic genes - DRD2, DBH, and DAT1. Am J Med Genet 1996;67:288.
43. Rowe DC, Van den Oord EJCG, Stever C, Giedinghagen LN, Gard JMC, Cleveland HH, et al. The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder. Mol Psychiatry 1999;4:580-6.
44. Madrid GA, MacMurray J, Lee JW, Anderson BA, Comings DE. Stress as a mediating factor in the association between the DRD2 TaqI polymorphism and alcohohsm. Alcohol 2001;23:117-22.
45. Berman SM, Noble EP. The D2 dopamine receptor (DRD2) gene and family stress; interactive effects on cognitive functions in children. Behav Genet 1997;27:33-43.
46. Ekman A, Nissbrandt H, Heilig M, Dijikstra D, Eriksson E. Central administration of dopamine D3 receptor antisense to rat: effects on locomotion, dopamine release, and [3H]spiperone binding. Naunyn Schmiedebergs Arch Pharmacol 1998;358:342-50.
47. Le Coniat M, Sokoloff P, Hillion J, Martres MP, Giros B, Pilon C, et al. Chromosomal localization of the human D3 dopamine receptor gene. Hum Genet 1991;87:618-20.
48. Rietschel M, Nothen MM, Lannfelt L, Sokoloff P, Schwartz JC, Lanczik M, et al. A serine to glycine substitution at position 9 in the extracellular N-terminal part of the dopamine D3 receptor protein: no role in the genetic predisposition to bipolar affective disorder. Psychiatry Res 1993;46:253-9.
49. Lundstrom K, Turpin MP. Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the samliki forest virus system. Biochem Biophy Res Commun 1996;225:1068-72.
50. Crocq MA, Mant R, Asherson P, Williams J, Hode Y, Mayerova A, et al. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 1992;29:858-60.
51. Barr CL, Wigg KG, Wu J, Zai C, Bloom S, Tannock R, et al. Linkage study of two polymorphisms at the dopamine D3 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet 2000;96:114-7.
52. Payton A, Holmes J, Barret JH, Hever T, Fitzpatrick H, Trumper AL, et al. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: A family-based study. Am J Med Genet 2001;105:464-70.
53. Muglia P, Jain U, Kennedy JL. A transmission disequilibrium test of the Ser9/Gly dopamine D3 receptor gene polymorphism in attention-deficit hyperactivity disorder. Behav Brain Res 2002;130:91-5.
54. Van Tol HHM, Wu CM, Guan H-C, Ohara K, Bunzow JR, Civelli O, et al. Multiple dopamine D4 receptor variants in the human population. Nature 1992;358:149-52.
55. Chang F-M, Kidd JR, Livak KJ, Pakstis AJ, Kidd KK. The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Hum Genet 1996;98:91-101.
56. Leung PWL, Luk SL, How TP, Taylor E, Mak FL, Bacon-Shone J. The diagnosis and prevalence of hyperactivity in Chinese schoolboys. Br J Psychiatry 1996;168:486-96.
57. Rubinstein M, Phillips TJ, Bunzow JR, Dziewczapolski G, Zhang G, Fang Y, et al. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 1997;90:991-1001.
58. Mill J, Curran S, Kent L, Richards S, Gould A, Virdee V, et al. Attention deficit hyperactivity disorder (ADHD) and the dopamine D4 receptor gene: evidence of association but no linkage in a UK sample. Mol Psychiatry 2001;6:440-4.
59. Muglia P, Jain U, Macciardi FM, Kennedy JL. Adult attention deficit hyperactivity disorder and the dopamine D4 receptor gene. Am J Med Genet 2000;96:273-7.
60. Comings DE, Gonzalez N, Wu S, Gade R, Muhleman D, Saucier G, et al. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am J Med Genet 1999;88:358-68.
61. Rowe DC, Stever C, Giedinghagen LN, Gard JMC, Cleveland HH, Terris ST, et al. Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol Psychiatry 1998;3:419-26.
62. Swanson JM, Sunohara CA, Kennedy JL, Regino R, Fineberg E, Wigal T, et al. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry 1998;3:38-41.
63. Castellanos FX, Lau E, Tayebi N, Lee P, Long RE, Giedd JN, et al. Lack of association between a dopamine-4 receptor polymorphism and attention-deficit/hyperactivity disorder: genetic and morphometric analysis. Mol Psychiatry 1998;3:431-4.
64. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996;1:121-4.
65. McCracken JT, Smalley SL, McGough JJ, Crawford L, Del'Homme M, Cantor RM, et al. Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Mol Psychiatry 2000;5:531-6.
66. Barr CL, Wigg KG, Bloom S, Schachar R, Tannock R, Roberts W, et al. Further evidence from haplotype analysis for linkage of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet 2000;96:262-7.
67. Kotler M, Manor I, Sever Y, Eisenburg J, Cohen H, Ebstein RP, et al. Failure to replicate an excess of the long dopamine D4 exon III repeat polymorphism in ADHD in a family-based study. Am J Med Genet 2000;96:278-81.
68. Hawi Z, McCarron M, Kirley A, Daly G, Fitzgerald M, Gill M. No association of the dopamine DRD4 receptor (DRD4) gene polymorphism with attention-deficit hyperactivity disorder (ADHD) in the Irish population. Am J Med Genet 2000;96:268-72.
69. Tahir E, Yazgan Y, Cirakoglu B, Ozbay F, Waldman I, Asherson PJ. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol Psychiatry 2000;5:396-404.
70. Eisenberg J, Zohar A, Mei-Tal G, Steinberg A, Tartakovsky E, Gritsenko I, et al. A haplotype relative risk study of the dopamine D4 receptor (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD). Am J Med Genet 2000;96:258-61.
71. Faraone SV, Biederman J, Weiffenbach B, Keith T, Chu MP, Weaver A, et al. Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Ant J Psychiatry 1999;156:768-70.
72. Smalley SL, Bailey JN, Palmer CG, Cantwell DP, McGough JJ, Del'Homme MA, et al. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol Psychiatry 1998;3:427-30.
73. Seaman MI, Fisher JB, Chang F-M, Kidd KK. Tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4). Am J Med Genet 1999;88:705-9.
74. Barr CL, Feng Y, Wigg KG, Schachar R, Tannock R, Roberts W, et al. 5′-untranslated region of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet 2001;105:84-90.
75. Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 2001;158:1052-7.
76. Todd RD, Neuman RJ, Lobos EA, Jong Y-JI, Reich W, Heath AC. Lack of association of dopamine D4 receptor gene polymorphisms with ADHD subtypes in a population sample of twins. Am J Med Genet 2001;105:432-8.
77. Paterson AD, Sunohara GA, Kennedy JL. Dopamine D4 receptor gene: novelty or nonsense? Neuropsychopharmacology 1999;21:3-16.
78. Swanson J, Oosterlaan J, Murias M, Schuck S, Flodman P, Spence MA, et al. Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proc Natl Acad Sci U S A 2000;97:4754-9.
79. Posner MI, Raichle ME. Images of mind. New York: Sci Am Library; 1994.
80. Cravchik A, Gejman PV. Functional analysis of the human D5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities. Pharmacogenetics 1999;9:199-206.
81. Daly G, Hawi Z, Fitzgerald M, Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 1999;4:192-6.
82. Barr CL, Wigg KG, Feng Y, Zai C, Malone M, Roberts W, et al. Attention-deficit hyperactivity disorder and the gene for the dopamine D5 receptor. Mol Psychiatry 2000;5:548-51.
83. Tahir E, Yazgan Y, Cirakoglu B, Ozbay F, Waldman I, Asherson PJ. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol Psychiatry 2000;5:396-404.
84. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A 1998;95:9991-6.
85. Grossman MH, Emanuel BS, Budarf ML. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2. Genomics 1992;12:822-5.
86. Lundstrom K, Tenhunen J, Tilgmann C, Karhunen T, Panula P, Ulmanen I. Cloning, expression and structure of catechol-O-methyltransferase. Biochim Biophys Acta 1995;1251:1-10.
87. Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savlainen R, Ulmanen I. Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distant promoters. Eur J Biochem 1994;223:1049-59.
88. Bertocci B, Garotta G, Da Prada M, Lahm HW, Zurcher G, Virgallita G, et al. Immunoaffinity, purification and partial amino acid sequence analysis of catechol-O-methyltransferase from pig liver. Biochim Biophys Acta 1991;1080:103-9.
89. Lachman HM, Morrow B, Sphrintzen R. Association of codons 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 1996;67:468-72.
90. Palmatier MA, Kang AM, Kidd KK. Global variations in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 1999;46:557-67.
91. Carlson C, Papolos D, Pandita RK, Faedda GL, Veit S, Goldberg R, et al. Molecular analysis of velo-cardio-facial syndome patients with psychiatric disorders. Am J Hum Genet 1997;60:851-9.
92. Joober R, Gauthier J, Lal S, Bloom D, Lalonde P, Rouleau G, et al. Catechol-o-methyltransferase val-108/158-met gene variants associated with performance on the wisconsin card sorting test. Arch Gen Psychiatry 2002;59:662-3.
93. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, et al. Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001;98:6917-22.
94. Manor I, Kotler M, Sever Y, Eisenberg J, Cohen H, Ebstein RP, et al. Failure to replicate an association between the catechol-O-methyltransferase polymorphism and attention deficit hyperactivity disorder in a second, independently recruited Israeli cohort. Am J Med Genet 2000;96:858-60.
95. Tahir E, Curran S, Yazgan Y, Ozbay F, Cirakoglu B, Asherson P. No association between low- and high-activity catecholamine-methyl-transferase (COMT) and attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Am J Med Genet 2000;96:285-8.
96. Hawi Z, Millar N, Daly G, Fitzgerald M, Gill M. No association between catechol-O-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample. Am J Med Genet 2000;96:282-4.
97. Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I, et al. Haplotype relative risk study of catechol-O-methytransferase and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity allele with ADHD impulsive-hyerpactive people. Am J Med Genet 1999;88:497-502.
98. Barr CL, Wigg KG, Malone M, Schachar R, Tannock R, Roberts W, et al. Linkage study of catechol-O-methytransferase and attention-deficit hyperactivity disorder. Am J Med Genet 1999;88:710-3.
99. Zametkin A, Rapoport JL, Murphy DL, Linnoila M, Ismond D. Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy. Arch Gen Psychiatry 1985;42:962-6.
100. Craig SP, Buckle VJ, Lamoureux A, Mallet J, Craig IW. Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. Cytogenet Cell Genet 1988;48:48-50.
101. Wilson AF, Elston RC, Siervogel RM, Tran LD. Linkage of a gene regulating dopamine-beta-hydroxylase activity and the ABO blood group locus. Am J Hum Genet 1988;42:160-6.
102. Perry SE, Summar ML, Phillips JA 3rd, Robertson D. Linkage analysis of the human dopamine beta-hydroxylase gene. Genomics 1991;10:493-5.
103. Roman T, Schmitz M, Polanczyk GV, Eizirik M, Rohde LA, Hutz MH. Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxlyase gene. Am J Med Genet 2002;114:154-8.
104. Filipek PA, Semrud-Clikeman M, Steingard RJ. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997;48:589-601.
105. Castellanos FX. Toward a pathophysiology of attention-deficit hyperactivity disorder. Clin Pediatr 1997;36:381-93.
106. Comings DE. Why different rules are required for polygenic inheritance: lessons from studies of the DRD2 gene. Alcohol 1998;16:61-70.
107. Nakamura Y, Koyama K, Matsushima M. VNTR (variable number of tandem repeat) sequences as transcriptional, translational, or functional regulators. J Hum Genet 1998;43:149-52.
108. Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB, et al. Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry 2000;157:1700-3.
109. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000;22:133-9.
110. Michelhaugh SK, Fiskerstrand C, Lovejoy E, Bannon MJ, Quinn JP. The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem 2001;79:1033-8.
111. Asghari V, Sanyal S, Buchwaldt S, Paterson AD, Jovanovic V, Van Tol HHM. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 1995;65:1157-65.
112. Sanyal S, Van Tol HH. Dopamine D4 receptor-mediated inhibition of cyclic adenosine 3′,5′-monophosphate production does not affect prolactin regulation. Endocrinology 1997;138:1871-8.
113. Asghari V, Schoots O, van Kats S, Ohara K, Jovanovic V, Guan HC, et al. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. Mol Pharmacol 1994;46:364-73.
114. Jovanovic V, Guan HC, Van Tol HH. Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants. Pharmacogenetics 1999;9:561-8.
115. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991;148:565-77.
116. Astbury J, Orgill A, Bajuk B. Relationship between two-year behaviour and neurodevelopmental outcome at five years of very low-birthweight survivors. Dev Med Child Neuro 1987;29:370-9.
117. Milberger S, Biederman J, Faraone SV, Guite J, Tsuang MT. Pregnancy, delivery and infancy complications and attention deficit hyperactivity disorder: issue of gene-environment interaction. Biol Psychiatry 1997;41:65-75.
118. Sprich-Buckminster S, Biederman J, Milberger S, Faraone SV, Lehman BK. Are perinatal complications relevant to the manifestation of ADHD? Issues of comorbidity and familiarity. J Am Acad Child Adoles Psychiatry 1993;32:1032-7.
119. Szatmari P. The epidemiology of attention-deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 1992;1:361-71.